Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 2, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Anemia
Interventions
DRUG

Intravenous Ferric Carboxymaltose

Patients were given ferric carboxymaltose as a maximum single dose of 1000 mg diluted in 250 mL of sterile 0.9% normal saline as a slow infusion over 45 minutes.

DRUG

Intravenous Iron Sucrose

Patients received intravenous injections of iron sucrose complex, which contained 200 mg of elemental iron (equivalent to 2 ampoules of 5 ml), mixed in 100 ml of 0.9% normal saline and infused over a period of 30 minutes every other day for up to 5 doses.

Trial Locations (1)

63100

Bahawal Victoria Hospital, Bahawalpur

All Listed Sponsors
lead

Muhammad Aamir Latif

OTHER

NCT07115121 - Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients | Biotech Hunter | Biotech Hunter